EP Patent

EP2211866A1 — Antiemetic-oral contraceptive combination

Assigned to Lupin Ltd · Expires 2010-08-04 · 16y expired

What this patent protects

The present invention relates to a method of reducing the incidence of nausea and vomiting associated with the administration of oral contraceptive formulation and a method of preparation of oral contraceptive formulation comprising progestin and /or estrogen and an antiemetic. T…

USPTO Abstract

The present invention relates to a method of reducing the incidence of nausea and vomiting associated with the administration of oral contraceptive formulation and a method of preparation of oral contraceptive formulation comprising progestin and /or estrogen and an antiemetic. The preferred oral contraceptive formulation comprises of levonorgestrel and an antiemetic.

Drugs covered by this patent

Patent Metadata

Patent number
EP2211866A1
Jurisdiction
EP
Classification
—
Expires
2010-08-04
Drug substance claim
No
Drug product claim
No
Assignee
Lupin Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.